ARTICLE
18 December 2015

Mintz Levin Advisory Analyzes Health Care Qui Tam Litigation Trends

M
Mintz

Contributor

Mintz is a general practice, full-service Am Law 100 law firm with more than 600 attorneys. We are headquartered in Boston and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, and Washington, DC, as well as an office in Toronto, Canada.
Kevin's analysis highlights what many experienced practitioners already knew anecdotally to be true: that the volume of health qui tam litigation has grown rapidly in recent years.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Last week, my colleague Kevin McGinty published a fascinating advisory that provides a detailed analysis of data recently released by the Department of Justice ("DOJ") in its annual report on False Claims Act ("FCA") filings. This data spans 28 years (from October 1, 1987 through September 30, 2015) and tracks annual recoveries and investigations for various categories of FCA cases. DOJ also included statistics that break down cases and recoveries between investigations initiated by the government and actions filed by whistleblowers under the qui tam provisions of the FCA.

Kevin's analysis highlights what many experienced practitioners already knew anecdotally to be true: that the volume of health qui tam litigation has grown rapidly in recent years. Moreover, DOJ's statistics reveal that health care-related cases – specifically, privately-instituted health care-related qui tam cases – have overwhelmingly been the largest factor in the growth in FCA cases and recoveries over the past 20 years. Kevin's advisory includes a series of graphs of those statistical trends over time, which provide a striking illustration of the impact of this two-decade long explosion in health care qui tam litigation. You can read Kevin's advisory here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
18 December 2015

Mintz Levin Advisory Analyzes Health Care Qui Tam Litigation Trends

United States Food, Drugs, Healthcare, Life Sciences

Contributor

Mintz is a general practice, full-service Am Law 100 law firm with more than 600 attorneys. We are headquartered in Boston and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, and Washington, DC, as well as an office in Toronto, Canada.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More